Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Jevons

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Journal of Antimicrobial Chemotherapy|September 18, 2004
Susceptibility testing Pasteurella multocida by BSAC standardized methodologyJ M Andrews, G Jevons, N Brenwald, et al.
The Journal of Antimicrobial Chemotherapy|October 3, 2002
Comparison of the in vitro activities of several new fluoroquinolones against respiratory pathogens and their abilities to select fluoroquinolone resistanceF J Boswell, J M Andrews, G Jevons, et al.
The Journal of Antimicrobial Chemotherapy|September 16, 2003
In vitro susceptibility of ertapenem by BSAC standardized methodologyJ M Andrews, J P Ashby, G Jevons, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 1999
Antimicrobial resistance in gram-positive pathogens isolated in the UK between October 1996 and January 1997J Andrews, J Ashby, G Jevons, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 1999
Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopyA Soman, D Honeybourne, J Andrews, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2003
Determination of in vitro susceptibility to ABT-492 by BSAC standardized methodologyJ M Andrews, J P Ashby, G Jevons, et al.
The Journal of Antimicrobial Chemotherapy|June 25, 1999
The concentrations of clinafloxacin in alveolar macrophages, epithelial lining fluid, bronchial mucosa and serum after administration of single 200 mg oral doses to patients undergoing fibre-optic bronchoscopyD Honeybourne, J M Andrews, B Cunningham, et al.
The Journal of Antimicrobial Chemotherapy|December 26, 2001
The in vitro activity of BMS-284756, a new des-fluorinated quinoloneT M A Weller, J M Andrews, G Jevons, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2000
A comparison of antimicrobial resistance rates in Gram-positive pathogens isolated in the UK from October 1996 to January 1997 and October 1997 to January 1998J Andrews, J Ashby, G Jevons, et al.
The Journal of Antimicrobial Chemotherapy|March 5, 2003
Concentrations of garenoxacin in plasma, bronchial mucosa, alveolar macrophages and epithelial lining fluid following a single oral 600 mg dose in healthy adult subjectsJ Andrews, D Honeybourne, G Jevons, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of Antimicrobial Chemotherapy|September 18, 2004
Susceptibility testing Pasteurella multocida by BSAC standardized methodologyJ M Andrews, G Jevons, N Brenwald, et al.
The Journal of Antimicrobial Chemotherapy|October 3, 2002
Comparison of the in vitro activities of several new fluoroquinolones against respiratory pathogens and their abilities to select fluoroquinolone resistanceF J Boswell, J M Andrews, G Jevons, et al.
The Journal of Antimicrobial Chemotherapy|September 16, 2003
In vitro susceptibility of ertapenem by BSAC standardized methodologyJ M Andrews, J P Ashby, G Jevons, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 1999
Antimicrobial resistance in gram-positive pathogens isolated in the UK between October 1996 and January 1997J Andrews, J Ashby, G Jevons, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 1999
Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopyA Soman, D Honeybourne, J Andrews, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2003
Determination of in vitro susceptibility to ABT-492 by BSAC standardized methodologyJ M Andrews, J P Ashby, G Jevons, et al.
The Journal of Antimicrobial Chemotherapy|June 25, 1999
The concentrations of clinafloxacin in alveolar macrophages, epithelial lining fluid, bronchial mucosa and serum after administration of single 200 mg oral doses to patients undergoing fibre-optic bronchoscopyD Honeybourne, J M Andrews, B Cunningham, et al.
The Journal of Antimicrobial Chemotherapy|December 26, 2001
The in vitro activity of BMS-284756, a new des-fluorinated quinoloneT M A Weller, J M Andrews, G Jevons, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2000
A comparison of antimicrobial resistance rates in Gram-positive pathogens isolated in the UK from October 1996 to January 1997 and October 1997 to January 1998J Andrews, J Ashby, G Jevons, et al.
The Journal of Antimicrobial Chemotherapy|March 5, 2003
Concentrations of garenoxacin in plasma, bronchial mucosa, alveolar macrophages and epithelial lining fluid following a single oral 600 mg dose in healthy adult subjectsJ Andrews, D Honeybourne, G Jevons, et al.
Pageof 2